Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 24 of 24 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/26/19
End: 06/30/23
Due: 06/30/24
Phase: N/A
Priority: Normal
Start: 04/01/25
End: 10/01/26
Due: 10/01/27
Phase: N/A
Priority: Normal
Start: 12/31/25
End: 12/01/27
Due: 12/01/28
Phase: N/A
Priority: Normal
Start: 09/30/11
End: 01/31/16
Due: 01/31/17
Phase: N/A
Priority: Normal
Start: 10/09/23
End: 08/31/24
Due: 08/31/25
Phase: N/A
Priority: Normal
Start: 06/03/24
End: 09/13/24
Due: 09/13/25
Phase: N/A
Priority: Normal
Start: 05/31/10
End: 10/31/12
Due: 10/31/13
Phase: N/A
Priority: Normal
Start: 11/12/24
End: 04/30/26
Due: 04/30/27
Phase: N/A
Priority: Normal
Start: 05/01/24
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 03/01/24
End: 01/01/27
Due: 01/01/28
Phase: N/A
Priority: Normal
Start: 01/04/22
End: 09/30/23
Due: 09/30/24
Phase: N/A
Priority: Normal
Start: 11/20/17
End: 05/04/21
Due: 05/04/22
Phase: N/A
Priority: Normal
Start: 06/20/20
End: 12/31/21
Due: 12/31/22
Phase: N/A
Priority: Normal
Start: 06/25/24
End: 09/27/24
Due: 09/27/25
Phase: N/A
Priority: Normal
Start: 07/01/25
End: 10/01/27
Due: 10/01/28
Phase: N/A
Priority: Normal
Start: 01/01/25
End: 12/31/28
Due: 12/31/29
Phase: N/A
Priority: Normal
Start: 03/23/21
End: 02/01/22
Due: 02/01/23
Phase: N/A
Priority: Normal
Start: 09/11/17
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 06/16/21
End: 02/28/25
Due: 02/28/26
Pharmacokinetic and PHarmacodynamic Analysis and Evaluation of Teriparatide (PTH 1-34) Between Sexes
Phase: N/A
Priority: Normal
Start: 05/24/21
End: 07/09/21
Due: 07/09/22
Phase: N/A
Priority: Normal
Start: 04/02/20
End: 05/31/25
Due: 05/31/26
Phase: N/A
Priority: Normal
Start: 10/15/20
End: 01/31/23
Due: 01/31/24
Phase: N/A
Priority: Normal
Start: 09/23/20
End: 02/24/22
Due: 02/24/23
Phase: N/A
Priority: Normal
Start: 04/01/22
End: 03/31/25
Due: 03/31/26